AbCellera Biologics (ABCL) Goodwill & Intangibles (2020 - 2026)

AbCellera Biologics' Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $85.3 million for Q1 2026.

• Quarterly Goodwill & Intangibles fell 4.19% year-over-year to $85.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $85.3 million (down 4.19% YoY) and the FY2025 annual result came in at $86.2 million, down 4.15% from the prior year.
• Goodwill & Intangibles was $85.3 million for Q1 2026 at AbCellera Biologics, down from $86.2 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $208.8 million in Q1 2022 and bottomed at $85.3 million in Q1 2026.
• A 5-year average of $140.4 million and a median of $166.5 million in 2024 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles surged 549.53% — and 2025, when it sank 46.56%.
• AbCellera Biologics' Goodwill & Intangibles stood at $179.3 million in 2022, then decreased by 6.18% to $168.2 million in 2023, then slumped by 46.55% to $89.9 million in 2024, then fell by 4.15% to $86.2 million in 2025, then dropped by 1.07% to $85.3 million in 2026.
• Business Quant data shows ABCL's Goodwill & Intangibles at $85.3 million in Q1 2026, $86.2 million in Q4 2025, and $87.1 million in Q3 2025.